Uses of Rebagen 100mg Tablet
Rebagen 100mg Tablet is used for the treatment or prevention of the following disease(s):
Mucosal Protection, Healing of Gastroduodenal Ulcers and Treatment of Gastritis
Side effects of Rebagen 100mg Tablet
The most common side effects of Rebagen 100mg Tablet are - Constipation, Bloating, Diarrhea, Nausea, Vomiting
These side effects can usually occur in patients. However, these are only indicative and not all patients will experience them.
Precautions while taking Rebagen 100mg Tablet
Do not use Rebagen 100mg Tablet if you are allergic to - Rebamipide
If you have heart disease, liver or kidney disease, drug or alcohol addiction, consult your doctor before using Rebagen 100mg Tablet.
If you are allergic to any medicine or food, consult your doctor before using this medicine.
Use this medicine under the supervision of your doctor.
To avoid an adverse reaction, consult your doctor if you are already taking other medicines.
Dosage of Rebagen 100mg Tablet
Rebagen 100mg Tablet contains - Rebamipide
Rebamipide enhances mucosal defense, scavenging free radicals, temporarily activating genes encoding cyclooxygenase-2.
Overdose of Rebagen 100mg Tablet
The dosage of Rebagen 100mg Tablet depends on many factors such as the patient age, health, medical condition or history of the patient and many other conditions.
Please use this medicine as prescribed by your doctor.
Onset of Action of Rebagen 100mg Tablet
If you forget to take a dose of Rebagen 100mg Tablet, do not take two doses at the same time, there is a risk of overdose.
If you notice any unusual reaction in your body after taking this medicine, contact your doctor immediately or call your local medical emergency number.
Duration of Action of Rebagen 100mg Tablet
Precautions & Warnings
Alcohol
Information will be added soon.
Pregnancy
Information will be added soon.
Breastfeeding
Information will be added soon.
Driving
Information will be added soon.
Kidney
Information will be added soon.
Liver
Information will be added soon.
Interactions
Information will be added soon.